Optimi Health (NASDAQ:OPTH) outlined its commercial strategy for natural psilocybin and other psychedelic compounds, highlighting its operations in Australia, clinical-development plans and potential regulatory opportunities in Canada and the United States. During a presentation, an Optimi representative said the company was founded in 2020 and operates a production facility in Princeton, British Columbia, with offices […]